» Articles » PMID: 18532920

Pulmonary Cell Culture Models to Study the Safety and Efficacy of Innovative Aerosol Medicines

Overview
Publisher Informa Healthcare
Specialty Pharmacology
Date 2008 Jun 6
PMID 18532920
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pulmonary cell culture models for the development of new aerosol medicines are attracting increasing interest. Ease of handling, ethical acceptance and high explanatory power are the main advantages of cell culture systems in pulmonary drug research.

Objective: Pulmonary cell culture models are described and evaluated regarding their suitability for the biopharmaceutical characterisation of innovative aerosol medicines.

Methods: The review focuses on the peculiarities of the pulmonary cell culture models arising from the specialised pulmonary epithelia, the clearance systems in the lung and the limited but functionalised lung fluid layers. Additional aerosol deposition systems suitable for the close to in vivo simulation of aerosol delivery on pulmonary cell cultures are described.

Results: Suitable cell culture models of the cellular part of the human air-blood barrier are established and well characterised. However, the physical barriers on top of the cellular barriers - surfactant, mucus and so on - and their influence on the safety and efficacy of aerosol medicines, are still underestimated.

Citing Articles

Optimizations of In Vitro Mucus and Cell Culture Models to Better Predict In Vivo Gene Transfer in Pathological Lung Respiratory Airways: Cystic Fibrosis as an Example.

Ghanem R, Laurent V, Roquefort P, Haute T, Ramel S, Le Gall T Pharmaceutics. 2021; 13(1).

PMID: 33396283 PMC: 7823756. DOI: 10.3390/pharmaceutics13010047.


An Inflamed Human Alveolar Model for Testing the Efficiency of Anti-inflammatory Drugs .

Drasler B, Karakocak B, Tankus E, Barosova H, Abe J, de Almeida M Front Bioeng Biotechnol. 2020; 8:987.

PMID: 32974315 PMC: 7471931. DOI: 10.3389/fbioe.2020.00987.


Innovative preclinical models for pulmonary drug delivery research.

Ehrmann S, Schmid O, Darquenne C, Rothen-Rutishauser B, Sznitman J, Yang L Expert Opin Drug Deliv. 2020; 17(4):463-478.

PMID: 32057260 PMC: 8083945. DOI: 10.1080/17425247.2020.1730807.


In vitro cell integrated impactor deposition methodology for the study of aerodynamically relevant size fractions from commercial pressurised metered dose inhalers.

Haghi M, Traini D, Young P Pharm Res. 2014; 31(7):1779-87.

PMID: 24549816 DOI: 10.1007/s11095-013-1282-2.


Ciprofloxacin is actively transported across bronchial lung epithelial cells using a Calu-3 air interface cell model.

Ong H, Traini D, Bebawy M, Young P Antimicrob Agents Chemother. 2013; 57(6):2535-40.

PMID: 23507281 PMC: 3716180. DOI: 10.1128/AAC.00306-13.